Synairgen plc (LON:SNG – Get Free Report)’s share price reached a new 52-week low during trading on Wednesday . The stock traded as low as GBX 3 ($0.04) and last traded at GBX 3.35 ($0.04), with a volume of 101650 shares changing hands. The stock had previously closed at GBX 3.45 ($0.05).
Synairgen Stock Performance
The company has a current ratio of 6.77, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09. The stock has a fifty day moving average price of GBX 4.32 and a 200-day moving average price of GBX 5.32. The firm has a market capitalization of £8.10 million, a price-to-earnings ratio of -100.50 and a beta of -2.23.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Read More
- Five stocks we like better than Synairgen
- The Risks of Owning Bonds
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- Upcoming IPO Stock Lockup Period, Explained
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
